-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Neutral on Minerva Neurosciences, Maintains $5 Price Target

Benzinga·11/06/2024 11:56:35
Listen to the news
HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $5 price target.